Search Results

Pharm Country

Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection

Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.

March 27, 2024

·

7 min read

Pictured: Loaded syringe and opioids_iStock, Darwi

Legal

Purdue Pharma, Sacklers Settle Opioid Lawsuits For $7.4B

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid crisis, according to the office of Massachusetts Attorney General Andrea Joy Campbell.

January 24, 2025

·

2 min read

·

Tristan Manalac

Pharm Country

Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection

Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).

March 28, 2023

·

6 min read

Pharm Country

FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose

Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.

April 8, 2024

·

6 min read

Press Releases

Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 8, 2025

·

1 min read

Business

Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer

Alkeus Pharmaceuticals, Inc. today announced that Eric L. Trachtenberg, J.D., M.B.A., has joined the company as Chief Legal Officer.

May 29, 2024